Dallas-Based EllaDx Launches National Lab Testing Platform Designed Around Women’s Symptoms
EllaDx Platform on iPhone. Photo Courtesy of EllaDx
Dallas, TX — According to the official press release, EllaDx, a Dallas-based, direct-to-consumer women’s health lab testing platform, announced its official national launch today. Designed by women, for women, EllaDx gives individuals across the country direct access to lab testing and educational information that can support more informed conversations about their health, without insurance or doctor’s referral required. Built around the complexity of women’s health, the platform is designed to support questions that arise across every stage of life, from fertility and metabolic health to thyroid function, menopause and longevity.
When asked about the mission behind the new brand, Kristen Tonkin, Director of Community Education and Engagement said,
“We built EllaDx because too many women were leaving the doctor’s office with a normal result, while the symptom that brought them in hadn’t gone away. For decades, medical research and standard testing were built around male bodies, and women have been catching up to that gap ever since. We wanted women to have real information about what was happening in their own bodies, not a generic panel that wasn’t built with them in mind. When a woman has that information, she stops second-guessing herself and starts advocating for her own health. That’s what this company was built to change.”
For many women, the path from recognizing that something feels wrong to obtaining meaningful information can take years. According to the American Journal of Obstetrics & Gynecology endometriosis alone is associated with diagnostic delays of four to 11 years after symptoms begin. EllaDx was built to help close the information gap that often exists between symptoms and care. By combining a symptom-guided digital experience with clinical-grade laboratory testing and research-informed education, the company gives users a clearer starting point: objective data that can be tracked over time and brought directly into conversations with healthcare providers. The platform is not intended to diagnose or replace medical care; it is designed to make relevant health information more accessible, understandable and actionable.
The vision to make this scientific data more accessible began with husband-and-wife founders Ali and Arsenio Aaron. As an acute care nurse practitioner, Ali saw firsthand how limited access to testing and delayed intervention could allow manageable health concerns to become more serious. Arsenio brought operational expertise shaped by years in business leadership and service in the U.S. Marine Corps. Together, they developed EllaDx to pair clinical insight with scalable technology, creating a thoughtfully designed platform that meets women earlier in the process and helps them arrive at healthcare appointments with organized information rather than unanswered questions.
How it Works
EllaDx offers two testing pathways: 10 ready-made panels spanning hormone and longevity, metabolic and organ function, cardiovascular health, micronutrients and cellular health, heavy metals, autoimmune and inflammation, thyroid, fertility, bone health, anemia and blood health. Users can take a three-minute symptom quiz to identify relevant ready-made panels or build a custom panel around their specific health questions and goals.
Blood draws are completed through CLIA-certified Quest Diagnostics laboratories at more than 2,250 locations nationwide. For ready-made panels, at-home blood draws are also available through a certified phlebotomist in covered ZIP codes. Most results are available in approximately five days, although some advanced tests can take up to 21 days. Results are delivered through a secure digital portal that presents standard laboratory reference ranges alongside plain-language, research-informed educational context. Users can retain or share reports with a healthcare provider and, when testing is repeated, track individual markers over time. The platform also records cycle phase with applicable results and supports cycle-timed testing, recognizing that hormone levels can shift throughout the menstrual cycle and that timing can materially affect the information a test provides.
EllaDx Annual is available for $79, while other ready-made panels are $149. Build-your-own panels are priced by biomarker, with a minimum of five biomarkers and a minimum panel total of $49; available after first purchase. This flexible structure recognizes that women may have different symptoms and testing needs at different stages of life, including ongoing health concerns that may benefit from comparing results over time. Panels are HSA- and FSA-eligible, require no subscription, and do not require insurance or a prior referral. In supported states, a licensed physician reviews and signs each laboratory order; EllaDx does not provide medical interpretation, diagnosis or treatment.
About ELLADX
EllaDx is a direct-to-consumer women's health lab testing platform offering 10 symptom-driven panels covering more than 180 biomarkers, along with a custom panel built from a short intake quiz. Each panel is organized around the way women actually present clinically, from hormonal shifts and fertility planning to metabolic health and perimenopause, rather than broad, generic testing categories. No physician referral or insurance approval is required. EllaDx was founded by Ali Aaron, NP, and Arsenio Aaron, a U.S. Marine Corps veteran, to close a persistent gap in women's healthcare: symptoms that are real but routinely go unexamined by standard labs. The platform gives women lab-grade data they can use to advocate for themselves and inform care decisions alongside their healthcare providers. Learn more at www.elladx.com.
An exclusive launch event on Saturday, September 19, 2026, in Dallas will mark the company’s national debut and recognize the work behind a platform designed to give women clearer access to their own health information.
Frequently Asked Questions
-
No.
EllaDx is direct-to-consumer — users can order lab testing without a physician referral or insurance approval. In supported states, a licensed physician reviews and signs each lab order as part of the process.
-
EllaDx Annual is available for $79. Individual ready-made panels are $149. Build-your-own panels start at a $49 minimum (five biomarkers minimum), available after a first purchase. Panels are HSA- and FSA-eligible.
-
Through CLIA-certified Quest Diagnostics locations — over 2,250 nationwide. At-home draws via a certified phlebotomist are also available for ready-made panels in covered ZIP codes.
-
Most results are available in approximately five days; select advanced tests can take up to 21 days.
-
Ten symptom-driven panels spanning hormone and longevity, metabolic and organ function, cardiovascular health, micronutrients and cellular health, heavy metals, autoimmune and inflammation, thyroid, fertility, bone health, and anemia/blood health — covering more than 180 biomarkers total.
-
EllaDx was founded by Ali Aaron, an acute care nurse practitioner, and her husband Arsenio Aaron, a U.S. Marine Corps veteran with a background in business operations.
-
EllaDx is a Dallas-based company, and its national launch event will be held in Dallas on Saturday, September 19, 2026.
